Match Document Document Title
9937216 Method for suppressing proliferation and/or inducing apoptosis of cancer cells  
It is to provide an agent for suppressing proliferation and/or inducing apoptosis of cancer cells that can be used for the treatment and chemoprophylaxis of cancer, wherein the agent is easily...
9937193 Method for treating a cancer  
The present invention relates to a method for treating a cancer with the combination of a topoisomerase II inhibitor (TOP2 inhibitor) and a histone deacetylation inhibitor (HDACi), provides...
9937179 Combined treatment for cancer resistant to an epidermal growth factor receptor kinase inhibitor  
The present invention provides a method for treating a cancer, comprising (a) identifying a patient with acquired resistance to an EGFR kinase inhibitor; and (b) administering to the patient an...
9937170 Treatment of cancer with TOR kinase inhibitors  
Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor...
9937169 Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy  
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound and an effective amount of an androgen receptor...
9934364 Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis  
The present disclosure provides methods for applying artificial neural networks to flow cytometry data generated from biological samples to diagnose and characterize cancer in a subject.
9932641 Fusion genes associated with progressive prostate cancer  
The present invention relates to methods and compositions for determining whether a subject having prostate cancer is at greater risk of developing progressive disease, and methods of treating the...
9932640 Clinical use of an Alu element based bioinformatics methodology for the detection and treatment of cancer  
The present invention relates generally to the field of human genetics. More specifically, this invention relates to the clinical application of a bioinformatics methodology described in patent...
9932405 Use of chimeric antigen receptor modified cells to treat cancer  
The present disclosure relates to compositions and methods for compositions, methods, and kits for treating cancer using chimeric antigen receptor (CAR) modified cells. Some embodiments of the...
9932389 Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer  
A chemoembolic agent is disclosed that includes an injectable, recombinantly synthesized silk-elastin like protein copolymer and one or more chemotherapeutic agents. Upon injection, the...
9932310 DNA2 inhibitors for cancer treatment  
Disclosed herein, inter alia, are compositions and methods for inhibiting DNA2.
9932288 Chemical compound for inhibition of SHP2 function and for use as an anti-cancer agent  
This invention provides a compound that is 4,4′-(4′-Carboxy)-4-nonyloxy-[1,1′-biphenyl]-3,5-diyl)dibuta noic acid (CNBDA), derivative compounds of CNBDA, and pharmaceutical compositions thereof....
9931416 Anti-claudin 1 antibodies for use in the treatment of colorectal cancer  
The present invention relates to anti-claudin 1 antibodies for use in the treatment of colorectal cancer. In particular, the present invention relates to a method of treating a colorectal cancer...
9931406 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant  
Disclosed is a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof and a non-metallic salt lubricant, which can be used as an effective cancer...
9931387 Cancer vaccine for cats  
The present invention provides a nucleic acid, or an immunogenic composition thereof, that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment...
9931373 Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein  
Disclosed are pharmaceutical and synergistic compositions human recombinant alpha-fetoprotein expressed in eukaryotic cells for preparation of therapeutic agents for use in oncology,...
9931359 Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancer  
The invention provides methods and compositions for administration of allogeneic lymphocytes as an exogenous source of CD4+ T cell help for endogenous, tumor-reactive CD8+ T cells. Depletion of...
9931355 Combination of compounds derived from gallic acid for the treatment of cancer  
The invention relates to a combination of compounds derived from gallic acid, with an antitumoral and antimetastatic activity via a mechanism that involves the induction of apoptosis and the...
9931342 Compositions and methods for the treatment of cancer  
The present disclosure provides compositions and methods for the treatment of cancer, relating to the specific inhibition of Abelson (ABL) kinases.
9931339 Substituted pyrrolo[2,3-b]quinoxalines for cancer therapy  
Compounds, including quinoxaline derivatives of formula I, for use in the treatment of cancer are described. In general, the compounds inhibit the import of proteins and transcription factors such...
9931331 Pharmaceutical composition for preventing or treating cancer, containing proteasome inhibitor and loperamide as active ingredients  
The present invention relates to an anticancer supplement containing loperamide as an active ingredient. More specifically, a proteasome inhibitor alone cannot exhibit an anticancer effect on...
9931322 Treatment of BRCA1-defective cancer or resistant cancers  
Provided herein are methods of treating cancer in a subject, by administering COH29 ((N-(4-(3,4-dihydroxyphenyl)-5-phenylthiazol-2-yl)-3,4-dihyd roxybenzamide)). The methods of treating include...
9931314 Method for treating skin cancer  
A method for treating skin cancer including the steps of applying an isothiocyanate functional surfactant to an area affected by skin cancer, wherein the isothiocyanate functional surfactant...
9931039 Methods related to real-time cancer diagnostics at endoscopy utilizing fiber-optic Raman spectroscopy  
A method of achieving instrument independent measurements for quantitative analysis of fiber-optic Raman spectroscope system, the system comprising a laser source, a spectroscope and a fiber optic...
9927444 Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer  
Methods of determining cancer progression or cancer relapse in a subject at risk for cancer progression or cancer relapse, the methods comprising: obtaining a sample from said subject; measuring...
9926607 Breast cancer biomarkers and methods of using same  
The present invention provides breast cancer markers based on RECQL mutations, and related methods, uses, agents, and kits. The invention includes methods for determining the susceptibility of a...
9926605 Functional genomics screening platform for head and neck cancer  
The present invention relates to HPV-positive as well as HPV-negative screening platforms that are highly serum-dependent, for use as HNSCC models. These HNSCC models die reproducibly in...
9926602 Recurrent gene fusions in prostate cancer  
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to...
9926601 Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer  
The present invention provides a method for identifying a tumor as likely to metastasize, or likely to have metastasized, comprising obtaining a sample of the tumor and quantitating alternatively...
9926374 Human immune therapies using a CD27 agonist in combination with another immune agonist to treat cancer  
Methods of inducing T cell proliferation and expansion in vivo for treating conditions wherein antigen-specific T cell immune response are therapeutically desirable such as cancer, infection,...
9926369 Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody  
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human...
9926334 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Compositions to detect remnant cancer cells
 
Disclosed are compounds, compositions and methods for detecting remnant cancer cells in a tissue sample.
9925269 Phospholipid ether analogs as cancer-targeting drug vehicles  
The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these...
9925240 Methods of treating and preventing cancer drug resistance  
Provided herein are combination therapies for the treatment of pathological conditions, such as cancer, using an antagonist of FGFR signaling.
9925192 Method for treating cancer  
A method for the treatment of cancer by administering a therapeutically effective amount of a cyclin-dependent kinase (CDK) inhibitor with a therapeutically effective amount of a B cell chronic...
9925142 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment  
The invention compositions comprising a continuous hydrophobic phase and liposomes as a vehicle for delivery of an antigen capable of inducing a cytotoxic T lymphocyte (CTL) response and methods...
9921224 Use of CD36 to identify cancer subjects for treatment  
Provided herein are methods for identifying a subject with cancer for treatment with a Psap peptides. The subject is identified based on a level of CD36. Also provided herein are compositions and...
9920377 FALZ for use as a target for therapies to treat cancer  
The disclosure provides methods for predicting and/or determining whether a subject has cancer based on the level of expression of BPTF. The disclosure also provides methods for determining...
9920376 Method for determining lymph node metastasis in cancer or risk thereof and rapid determination kit for the same  
The objective of the present invention is to provide a method and a means of rapidly and reliably detecting lymph node metastasis in cancer or the risk of lymph node metastasis. Specifically, the...
9920297 Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1  
The present invention relates to an attenuated mutant strain of Salmonella comprising a recombinant DNA molecule encoding Wilms' tumor Protein 1. In particular, the present invention relates to...
9920130 Recombinant human IgM-antibody effective against cancer cells  
A recombinant human monoclonal pentameric IgM antibody comprising the capability of oligospecific binding to purified ganglioside epitopes GD3, GM3, GD2 and GM1 and the capability of specific...
9920129 Diagnosis and treatment of cancer using anti-ITM2A antibody  
Disclosed is a monoclonal antibody binding to an ITM2A protein. This antibody is useful in the diagnosis, prevention, and treatment of cancer such as Ewing's sarcoma, T cell leukemia, T cell...
9920099 Anti-cancer compositions containing Wnt decoy receptor  
The present invention relates to a composition for preventing or treating cancer comprising Wnt decoy receptor. The composition of the present invention or the expression product thereof inhibits...
9920095 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders  
The invention provides novel guanylate cyclase-C agonist peptides and their use in the treatment of human diseases including gastrointestinal disorder, inflammation or cancer (e.g., a...
9919062 Oncolytic vaccinia virus cancer therapy  
Embodiments of the invention are directed methods that include a thymidine kinase deficient vaccinia virus. The methods include administering the vaccinia virus at increased viral concentrations....
9919058 Polyketal particles including a CpG oligodeoxynucleotide for the treatment of lung cancer  
Methods are disclosed herein for treating a subject with a lung cancer. The lung cancer can be small cell carcinoma of the lung or non-small cell carcinoma of the lung. The methods include locally...
9919023 Anti-androgen peptides and uses thereof in cancer therapy  
The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro)n-His-Pro-His-Ala-Arg-Ile-Lys]m-Y. The...
9919016 Product and method of deploying kale derivatives for anti-cancer effects  
The present disclosure describes chemopreventative and/or chemotherapeutic compositions for inducing apoptosis in cancer cells which include kale and methods of inducing apoptosis in cancer cells...
9919000 Altering cancer cellular functions through proton mopping  
Proton mopping is a new anti-cancer therapeutic approach that disrupts cancer's immunologic balance. It results in the alteration of the pHi/pHe ratio (intracellular-extracellular) of the cancer...
9918983 Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells  
Disclosed are inhibitors of lysine-specific demethylase I (LSD1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating cancers...